We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-2.31%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$1.15B
AUM Growth
+$26M
Cap. Flow
+$61.3M
Cap. Flow %
5.35%
Top 10 Hldgs %
19.8%
Holding
2,267
New
104
Increased
524
Reduced
607
Closed
104

Sector Composition

Rank Sector Weight
1 Industrials 7.75%
2 Energy 7.46%
3 Technology 7.24%
4 Financials 6.48%
5 Consumer Staples 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
276
Qualcomm
QCOM
$158B
$593K 0.05%
10,717
-1,575
-13% -$100K
TMUS icon
277
T-Mobile US
TMUS
$190B
$584K 0.05%
9,575
-90
-0.9% -$5.63K
FTSL icon
278
First Trust Senior Loan Fund ETF
FTSL
$2.32B
$575K 0.05%
11,961
+456
+4% +$22K
OGS icon
279
ONE Gas
OGS
$4.92B
$570K 0.05%
8,636
+90
+1% +$6.06K
IBB icon
280
iShares Biotechnology ETF
IBB
$9.18B
$567K 0.05%
5,315
-504
-9% -$55.9K
SNN icon
281
Smith & Nephew
SNN
$13.5B
$567K 0.05%
14,888
-666
-4% -$24.1K
VCSH icon
282
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
$567K 0.05%
7,234
-21,828
-75% -$1.72M
SYY icon
283
Sysco
SYY
$40.5B
$565K 0.05%
9,425
+196
+2% +$11.9K
HPI
284
John Hancock Preferred Income Fund
HPI
$431M
$557K 0.05%
27,204
-10,690
-28% -$220K
TECH icon
285
Bio-Techne
TECH
$11.2B
$557K 0.05%
14,760
-260
-2% -$9.19K
COF icon
286
Capital One
COF
$133B
$556K 0.05%
5,809
-112
-2% -$11.1K
AMAT icon
287
Applied Materials
AMAT
$412B
$554K 0.05%
9,975
-6,430
-39% -$358K
HALO icon
288
Halozyme
HALO
$9.8B
$552K 0.05%
28,200
-300
-1% -$5.81K
IHI icon
289
iShares US Medical Devices ETF
IHI
$3.35B
$552K 0.05%
17,922
-330
-2% -$10.2K
GBDC icon
290
Golub Capital BDC
GBDC
$3.44B
$551K 0.05%
31,471
+666
+2% +$11.8K
LNC icon
291
Lincoln National
LNC
$8.83B
$550K 0.05%
7,539
-11
-0.1% -$863
WY icon
292
Weyerhaeuser
WY
$18B
$549K 0.05%
15,705
+11
+0.1% +$388
ARCC icon
293
Ares Capital
ARCC
$13.8B
$548K 0.05%
34,583
-684
-2% -$10.8K
EXC icon
294
Exelon
EXC
$46.8B
$541K 0.05%
19,456
+741
+4% +$20K
AFL icon
295
Aflac
AFL
$64.5B
$540K 0.05%
12,360
-1,074
-8% -$47.5K
VNQ icon
296
Vanguard Real Estate ETF
VNQ
$39.2B
$537K 0.05%
7,116
-301
-4% -$23K
SWKS icon
297
Skyworks Solutions
SWKS
$9.15B
$536K 0.05%
5,356
+112
+2% +$11.6K
VTR icon
298
Ventas
VTR
$47.1B
$527K 0.05%
10,651
-1,026
-9% -$53.8K
SBNY
299
DELISTED
Signature Bank
SBNY
$521K 0.05%
3,671
+728
+25% +$110K
DES icon
300
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
$519K 0.05%
18,960
-154
-0.8% -$4.35K

Similar funds

Geneos Wealth Management's Q1 2018 Portfolio in Review

As of Q1 2018, Geneos Wealth Management held 2,267 positions worth $1.15B, up 2.3% from $1.12B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneos Wealth Management deployed $61.3M of net new capital in Q1 2018, opening 104 new positions and adding to 524 existing holdings. Its largest new stake was WESCO International: 30,750 shares worth $1.91M.

By sector, the portfolio is most concentrated in Industrials at 7.7% of assets, up from 7.1% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Accelerate Diagnostics, an estimated $7.44M trimmed.

  • Geneos Wealth Management's largest Q1 2018 buy was WESCO International: 30,750 shares worth $1.91M.
  • Geneos Wealth Management added most to Anfield Diversified Alternatives ETF in Q1 2018, an estimated $12.1M increase.
  • Geneos Wealth Management's biggest Q1 2018 reduction was Accelerate Diagnostics, cutting an estimated $7.44M.
  • Geneos Wealth Management fully exited Eaton Vance Floating-Rate Income Trust in Q1 2018, selling an estimated $2.85M.
  • Geneos Wealth Management's ten largest holdings make up 20% of its $1.15B portfolio in Q1 2018.
  • Geneos Wealth Management opened 104 new positions and closed 104 in Q1 2018.
  • Geneos Wealth Management's portfolio value rose 2.3% quarter-over-quarter to $1.15B.

Based on Geneos Wealth Management's 13F filing for Q1 2018, filed 7 Sep 2021.